GSTM1 and inflammatory bowel disease: However, patients with recurrent UC presented a longer disease course, higher baseline levels of CRP and calprotectin, more pronounced anxiety and depression, greater severity of fecal incontinence, and lower BMI, Hb, ALB, and IBD-Q scores than did those with newly diagnosed UC (all P < 0.05; Table 1).